Amedisys Operating Expenses 2010-2024 | AMED

Amedisys operating expenses from 2010 to 2024. Operating expenses can be defined as the sum of all operating expenses for the given industry.
Amedisys Annual Operating Expenses
(Millions of US $)
2023 $2,080
2022 $2,042
2021 $1,975
2020 $1,887
2019 $1,778
2018 $1,507
2017 $1,433
2016 $1,362
2015 $1,290
2014 $1,181
2013 $1,404
2012 $1,550
2011 $1,888
2010 $1,390
2009 $1,246
Amedisys Quarterly Operating Expenses
(Millions of US $)
2024-09-30 $557
2024-06-30 $539
2024-03-31 $540
2023-12-31 $537
2023-09-30 $514
2023-06-30 $515
2023-03-31 $514
2022-12-31 $516
2022-09-30 $519
2022-06-30 $510
2022-03-31 $497
2021-12-31 $511
2021-09-30 $497
2021-06-30 $491
2021-03-31 $477
2020-12-31 $495
2020-09-30 $486
2020-06-30 $458
2020-03-31 $448
2019-12-31 $459
2019-09-30 $448
2019-06-30 $448
2019-03-31 $423
2018-12-31 $398
2018-09-30 $377
2018-06-30 $369
2018-03-31 $363
2017-12-31 $368
2017-09-30 $350
2017-06-30 $375
2017-03-31 $339
2016-12-31 $335
2016-09-30 $347
2016-06-30 $342
2016-03-31 $338
2015-12-31 $322
2015-09-30 $310
2015-06-30 $299
2015-03-31 $360
2014-12-31 $286
2014-09-30 $284
2014-06-30 $292
2014-03-31 $318
2013-12-31 $314
2013-09-30 $456
2013-06-30 $312
2013-03-31 $323
2012-12-31 $495
2012-09-30 $349
2012-06-30 $348
2012-03-31 $358
2011-12-31 $305
2011-09-30 $925
2011-06-30 $328
2011-03-31 $329
2010-12-31 $305
2010-09-30 $368
2010-06-30 $366
2010-03-31 $351
2009-12-31 $305
2009-09-30 $328
2009-06-30 $318
2009-03-31 $295
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $2.744B $2.236B
Amedisys Inc. provides home health and hospice services throughout the U.S. to the growing chronic, co-morbid, and aging American population. The company also offers clinically focused programs for chronic conditions and various diseases such as diabetes, coronary artery disease, congestive heart failure, orthopedics, complex wound care, geriatric surgical recovery, balance retraining, behavioral health and stroke recovery, as well as various rehabilitative programs. It provides hospice services to patients using an interdisciplinary care team comprising a physician, nurses, home health aides, social workers, therapists, dieticians, volunteers, counselors, chaplains and bereavement coordinators, when required. The company depends on reimbursement from Medicare (for chronic care) for a significant portion of its revenues on account of the age demographics of its patient base (average age of 81).
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $19.704B 11.92
Quest Diagnostics (DGX) United States $16.912B 17.14
DaVita (DVA) United States $12.098B 15.65
Encompass Health (EHC) United States $9.453B 22.29
Chemed (CHE) United States $7.853B 24.14
Elanco Animal Health (ELAN) United States $5.843B 13.91
RadNet (RDNT) United States $5.284B 117.02
Option Care Health (OPCH) United States $3.848B 18.23
LifeStance Health (LFST) United States $2.698B 0.00
Addus HomeCare (ADUS) United States $2.350B 27.57
Astrana Health (ASTH) United States $1.974B 26.99
U.S Physical Therapy (USPH) United States $1.380B 36.27
Pennant (PNTG) United States $0.938B 37.92
Aveanna Healthcare Holdings (AVAH) United States $0.873B 0.00
Atai Life Sciences (ATAI) Germany $0.200B 0.00
Bioqual (BIOQ) United States $0.059B 0.00
Daxor (DXR) United States $0.039B 0.00
Ontrak (OTRK) United States $0.006B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.005B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00
Psychemedics (PMD) United States $0.000B 0.00